Treatment of acute liver failure in pigs reduces hepatocyte function in a bioartificial liver support system

International Journal of Artificial Organs

Volumn 25, Issue 10, 2002, Pages 966-974

  Abrahamse, S L ^a   Van De Kerkhove, M P ^a   Sosef, M N ^a   Hartman, R ^a   Chamuleau, R A F M ^a   Van Gulik, T M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute liver failure; Bioartificial liver; Bioreactor; Cell culture; Hepatocytes; Liver support; Pigs

Indexed keywords

AMMONIA; ARTIFICIAL ORGANS; BIOCONVERSION; BIOREACTORS; CELLS; ENZYMES; ESTERS; MAMMALS; METABOLISM; PATIENT TREATMENT; UREA;

ACUTE LIVER FAILURE; BIOARTIFICIAL LIVER; BIOARTIFICIAL LIVER SUPPORT SYSTEM; BIOREACTOR; CELL VIABILITY; FUNCTIONAL ACTIVITIES; HEPATOCYTE FUNCTIONS; HEPATOCYTES; LIVER SUPPORT; PIG;

CELL CULTURE;

7 ETHOXYCOUMARIN DEETHYLASE; AMMONIA; CHOLINESTERASE; LACTATE DEHYDROGENASE; LACTIC ACID; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BIOREACTOR EQUIPMENT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL VIABILITY; CHEMICAL ANALYSIS; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; NONHUMAN; PLASMA; SWINE; UREA CYCLE;

EID: 0036815819     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501011     Document Type: Article

References (28)

1. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis 1996; 16: 435-44.
2. Dixit V, Gitnick G. The bioartificial liver: State-of-the-art. Eur J Surg 1996; 16: 435-44.
3. Nagamori S, Hasumura S, Matsuura T, Aizaki H, Kawada M. Developments in bioartificial liver research: Concepts, performance, and applications. J Gastroenterol 2000; 35: 493-503.
4. Busse B, Gerlach JC. Bioreactors for hybrid liver support: Historical aspects and novel designs. Ann NY Acad Sci 1999; 875: 326-39.
5. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology 2001; 34: 447-55.
6. Strain AJ, Neuberger JM. A bioartificial liver state of the art. Science 2002; 295: 1005-9.
7. Watanabe FD, Mulion CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997; 225: 484-94.
8. Ellis AJ, Hughes RD, Wendon IA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-51.
9. Chen SC, Hewitt WR, Watanabe FD, et al. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs 1996; 19: 664-9.
10. Detry O, Arkadopoulos N, Ting P, et al. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999; 65: 934-8.
11. Gove CD, Hughes RD, Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. Br J Exp Pathol 1982; 63: 547-53.
12. Catapano G, De Bartolo L, Lombardi CP, Drioli E. The effect of catabolite concentration on the viability and functions of isolated rat hepatocytes. Int J Artif Organs 1996; 19: 245-50.
13. Flendrig LM, La Soc JW, Joming GGA, et al. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound non-woven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997; 26: 1379-92.
14. Flendrig LM, Te Velde AA, Chamuleau RAFM. Semipermeable hollow fiber membranes in hepatocyte bioreactors: A prerequisite for a successful bioartificial liver? Artif Organs 1997; 21: 1177-81.
15. Fiendrig LM, Chamuieau RA, Maas MA, et al. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: Treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 1999;30:311-20.
16. Flendrig LM, Maas MA, Daaihuisen J, et al. Does the extent of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver? Int J Artif Organs 1998; 21: 542-7.
17. Flendrig LM, Cause F, Di Flono E, et al. Significant improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22: 701-8.
18. Sosef MN, Abrahamse SL, Van de Kerkhove M-P, Hartman R, Chamuleau RAFM, Van Gulik TM. Assessment of the AMC-bioartificial liver in the anhepatic pig. Transplantation 2002; 73:204-9.
19. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1975; 29-83.
20. Hoogenboom LAP, Pastoor FJH, Clous WE, Hesse SE, Kuiper HA. The use of pig hepatocytes for biotransformation studies of veterinary drugs. Xenobiotica 1989; 19: 1207-19.
21. Sakai Y, Naruse K, Nagashima I, Muto T, Suzuki M. In vitro function of porcine hepatocyte spheroids in 100% human plasma. Cell Transplant 1996; 5 (suppl): S41-3.
22. Sakai Y, Naruse K, Nagashima I, Muto T, Suzuki M. Functional stability of porcine hepatocyte spheroids in various culture systems under 100% porcine and human plasma conditions. Artif Organs 1996; 20: 56-60.
23. Takahashi M, Ishikura II, Takahashi C, et al. Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. ASAIO J 1993; 39: M242-6.
24. Baquerizo A, Mhoyan A, Shirwan H, et al. Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver. Transplant Proc 1997; 29: 964-5.
25. Bomemann R, Smith MD, Gerlach JC. Consideration of potential immunological problems in the application of xenogenic hybrid liver support. Int J Artif Organs 1996; 19: 655-63.
26. Eguchi S, Kawazoe Y, Sugiyama N, et al. Effects of anticoagulants on porcine hepatocytes in vitro: Implications in the porcine hepatocyte-based bioartificial liver. Int J Artif Organs 1999; 22: 329-33.
27. Nyberg SL, Hardin JA, Matos LE, Rivera DJ, Misra SP, Gores GJ. Cytoprotective influence of ZVAD-fmk and glycine on gel-entrapped rat hepatocytes in a bioartificial liver. Surgery 2000; 127: 447-55.
28. Rivera DJ, Gores GJ, Misra SP, Hardin JA, Nyberg SL. Apoptosis by gel-entrapped hepatocytes in a bioartificial liver. Transplant Proc 1999; 31: 671-3.